Sees FY25 adjusted EBITDA of $295 million to $335 million, reflecting an Adjusted EBITDA margin of 13% to 14%.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on HIMS:
- Hims and Hers Health options imply 14.9% move in share price post-earnings
- Hims & Hers Health (HIMS) Is About to Report Q2 Earnings. Here’s What to Expect
- Options Volatility and Implied Earnings Moves Today, August 04, 2025
- Is HIMS a Buy, Before Earnings?
- Option traders moderately bearish in Hims and Hers Health with shares down 5.67%